These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11854634)

  • 1. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study.
    Scalori A; Tavani A; Gallus S; La Vecchia C; Colombo M
    Am J Obstet Gynecol; 2002 Feb; 186(2):195-7. PubMed ID: 11854634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use.
    Fukahori S; Kawano T; Obase Y; Umeyama Y; Sugasaki N; Kinoshita A; Fukushima C; Yamakawa M; Omagari K; Mukae H
    Am J Case Rep; 2019 Jul; 20():1124-1127. PubMed ID: 31358723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study.
    Heinemann LA; Weimann A; Gerken G; Thiel C; Schlaud M; DoMinh T
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):194-200. PubMed ID: 10036602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cavernous hemangioma of the cervix in association with focal nodular hyperplasia of the liver. A case report.
    Padmanabhan V; Mount SL; Eltabbakh GH
    J Reprod Med; 2001 Dec; 46(12):1067-70. PubMed ID: 11789088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
    Tajada M; Nerín J; Ruiz MM; Sánchez-Dehesa M; Fabre E
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):227-30. PubMed ID: 11848652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)].
    Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W
    Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.
    Kubota T; Shimizu K; Sonoyama T; Ikeda E; Kurioka H; Ouchi T; Suyama Y; Hosokawa Y; Yamagishi H
    Hepatogastroenterology; 2001; 48(42):1736-9. PubMed ID: 11813612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for focal nodular hyperplasia of the liver: an Italian case-control study.
    Scalori A; Tavani A; Gallus S; La Vecchia C; Colombo M
    Am J Gastroenterol; 2002 Sep; 97(9):2371-3. PubMed ID: 12358258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver.
    Grabowski M; Stenram U; Bergqvist A
    Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):615-22. PubMed ID: 171910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature.
    Knowles DM; Wolff M
    Hum Pathol; 1976 Sep; 7(5):533-45. PubMed ID: 964980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal nodular hyperplasia of the liver and oral contraceptives.
    Kinch R; Lough J
    Am J Obstet Gynecol; 1978 Dec; 132(7):717-27. PubMed ID: 213973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of focal nodular hyperplasia of the liver after oral contraceptive discontinuation.
    Côté C
    Clin Nucl Med; 1997 Sep; 22(9):587-90. PubMed ID: 9298289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple nodular hyperplasia of liver associated with oral contraceptives (author's transl)].
    Roschlau G
    Zentralbl Allg Pathol; 1977; 121(6):517-21. PubMed ID: 607696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign liver lesions in female patients.
    Gray J; Diamond T
    Ulster Med J; 2000 May; 69(1):65-8. PubMed ID: 10881650
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive-dependent growth of focal nodular hyperplasia.
    Nakamuta M; Ohashi M; Fukutomi T; Tanabe Y; Hiroshige K; Nakashima O; Nawata H
    J Gastroenterol Hepatol; 1994; 9(5):521-3. PubMed ID: 7827306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.